Construction and analysis of a modified Tn4001 conferring chloramphenicol resistance in Mycoplasma pneumoniae

Plasmid

Volumn 41, Issue 2, 1999, Pages 120-124

  Hahn, Tae Wook ^a   Mothershed, Elizabeth A ^a   Waldo III, Robert H ^a   Krause, Duncan C ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM TRANSFORMATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME ASSAY; GENETIC TRANSFORMATION; MOLECULAR CLONING; MYCOPLASMA PNEUMONIAE; NONHUMAN; STRAIN DIFFERENCE;

BACTERIA (MICROORGANISMS); FELIS CATUS; MYCOPLASMA PNEUMONIAE; STAPHYLOCOCCUS AUREUS;

EID: 0032927860     PISSN: 0147619X     EISSN: None     Source Type: Journal    
DOI: 10.1006/plas.1998.1387     Document Type: Article

References (19)

1. Byrne M. E., Rouch D., Skurray R. A. Nucleotide sequence analysis of IS256Staphylococcus aureus4001. Gene. 81:1989;361-367.
2. Dower W. J., Miller J. F., Ragsdale C. W. High efficiency transformation ofE. coli. Nucleic Acids Res. 16:1988;6127-6145.
3. Dybig K. Mycoplasmal genetics. Annu. Rev. Microbiol. 44:1990;81-104.
4. Gillespie M. T., Lyon B. R., Messerotti L. J., Skurray R. A. Chromosome- and plasmid-mediated gentamicin resistance inStaphylococcus aureus4001. J. Med. Microbiol. 24:1987;139-144.
5. Hahn T.-W., Willby M. J., Krause D. C. HMW1 is required for cytadhesin P1 trafficking to the attachment organelle inMycoplasma pneumoniae. J. Bacteriol. 180:1998;1270-1276.
6. Hahn T.-W., Krebes K. A., Krause D. C. Expression inMycoplasma pneumoniae. Mol. Microbiol. 19:1996;1085-1093.
7. Hannan P. C. T. Antibiotic susceptibility ofMycoplasma fermentansin vitro. J. Med. Microbiol. 42:1995;421-428.
8. Hayes M. M., Foo H., Timenetsky J., Lo S. In vitro antibiotic susceptibility testing of clinical isolates ofMycoplasma penetrans. Antimicrob. Agents Chemother. 39:1995;1386-1387.
9. Hedreyda C. T., Krause D. C. Identification of a possible cytadherence regulatory locus inMycoplasma pneumoniae. Infect. Immun. 63:1995;3479-3483.
10. Hedreyda C. T., Lee K. K., Krause D. C. Transformation ofMycoplasma pneumoniae4001. Plasmid. 30:1993;170-175.
11. Horinouchi S., Weisblum B. Necleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J. Bacteriol. 150:1982;815-825.
12. Knudtson K. L., Minion C. Construction of Tn4001lac. Gene. 137:1993;217-222.
13. Krause D. C., Proft T., Hedreyda C. T., Hilbert H., Plagens H., Herrmann R. Transposon mutagenesis reinforces the correlation betweenMycoplasma pneumoniae. J. Bacteriol. 179:1997;2668-2677.
14. Lipman R. D., Clyde W. A. Jr. The interrelationship of virulence, cytadsorption, and peroxide formation inMycoplasma pneumoniae. Proc. Soc. Exp. Biol. Med. 131:1969;1163-1167.
15. Lipman R. P., Clyde W. A. Jr., Denny F. W. Characteristics of virulent, attenuated, and avirulentMycoplasma pneumoniae. J. Bacteriol. 100:1969;1037-1043.
16. Lyon B. R., May J. W., Skurray R. A. Tn4001:Staphylococcus aureus. Mol. Gen. Genet. 193:1984;554-556.
17. Rouch D. A., Byrne M. E., Kong Y. C., Skurray R. A. TheaacA-aphD4001Staphylococcus aureus: J. Gen. Microbiol. 133:1987;3039-3052.
18. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor.
19. Stevens M. K., Krause D. C. Localization of theMycoplasma pneumoniae. J. Bacteriol. 173:1991;1041-1050.